INVENTIVA (IVA) 3.145 EUR (+3.28%) | Healthcare & Biotech Euronext / Paris

Inventiva is a pharmaceutical company specializing in the development of innovative treatments for fibrotic diseases.

Momentum appears positive and sustained, reflecting renewed market interest in the story. The recent trend confirms a favorable dynamic, but this remains a speculative biotech profile: share-price upside mainly depends on the company’s ability to convert its research advances into tangible clinical validation.

INVENTIVA

Trend Analysis of INVENTIVA

Want to see the full analysis?